Beijing Chaoyang Hospital, Capital Medical University

Beijing, Beijing Municipality 100027

3 studies enrolling now · 13 studies all time

What they study most

Alopecia Areata, Ankylosing Spondylitis, Asthma, Breast Cancer, Cardiovascular Diseases, Central Nervous System Pathology, Cervical Cancer, Chronic Kidney Diseases, Contrast Enhancement in Magnetic Resonance Imaging, Coronary Artery Disease, Coronary Disease, Endometrial Carcinoma

Studies at this site

• A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma — Recruiting now
• A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma — Recruiting now
• Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma — Recruiting now
• Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01) — Running, not enrolling
• A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata — Completed
• Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM — Completed
• A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems) — Completed
• Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab — Running, not enrolling
• Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD) — Stopped early
• A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related Problems — Completed
• Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) — Stopped early
• ABY-035 in the Treatment of Subjects With Ankylosing Spondylitis — Stopped early
• International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) — Completed